Alternatives to Queen Mary University of London Spinouts

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

AI-driven digital twin of embryo development for cell-based therapies.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

Upcycles food waste into high-value lactic acid using climate-transformative technology.

Synthetic biology platform for environmental sustainability solutions.

Omnix Medical is developing a novel platform for advanced wound care management.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered insights platform for life sciences and biotech workflows.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Compressing biology to develop the next generation of therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.